8592 Stock Overview
China Regenerative Medicine International Limited, an investment holding company, engages in the production and sale of healthcare products and services in Hong Kong and the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
China Regenerative Medicine International Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.98 |
| 52 Week High | HK$0.98 |
| 52 Week Low | HK$0.70 |
| Beta | 1.75 |
| 1 Month Change | 12.64% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 8.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8592 | HK Biotechs | HK Market | |
|---|---|---|---|
| 7D | 0% | 2.9% | 2.5% |
| 1Y | n/a | -33.4% | -7.2% |
Return vs Industry: Insufficient data to determine how 8592 performed against the Hong Kong Biotechs industry.
Return vs Market: Insufficient data to determine how 8592 performed against the Hong Kong Market.
Price Volatility
| 8592 volatility | |
|---|---|
| 8592 Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 9.4% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 15.0% |
| 10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 8592 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 8592's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 29 | Chuang Wang | www.crmi.hk |
China Regenerative Medicine International Limited, an investment holding company, engages in the production and sale of healthcare products and services in Hong Kong and the People’s Republic of China. The company offers various health management services, such as assessment of health situation, treatment for detox, balance of inner body, nourishing organs, and enhancement of immune system; and beauty services, including non-surgical medical aesthetic services, basic skincare, solutions for youthful skin, hair revitalizing, lines firming, partial remodelling, and intimate rejuvenation treatment services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015.
China Regenerative Medicine International Limited Fundamentals Summary
| 8592 fundamental statistics | |
|---|---|
| Market cap | HK$188.38m |
| Earnings (TTM) | HK$15.10m |
| Revenue (TTM) | HK$245.45m |
12.5x
P/E Ratio0.8x
P/S RatioIs 8592 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8592 income statement (TTM) | |
|---|---|
| Revenue | HK$245.45m |
| Cost of Revenue | HK$190.34m |
| Gross Profit | HK$55.11m |
| Other Expenses | HK$40.01m |
| Earnings | HK$15.10m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.053 |
| Gross Margin | 22.45% |
| Net Profit Margin | 6.15% |
| Debt/Equity Ratio | 46.1% |
How did 8592 perform over the long term?
See historical performance and comparison